SNYR Synergy CHC Corp.

Nasdaq Medicinal Chemicals & Botanical Products NV CIK: 0001562733
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

Synergy CHC is in severe financial distress with negative stockholders equity (-$23.1M), indicating technical insolvency. The company is burning cash operationally (-$2.6M OCF) while experiencing declining revenue (-12.8% YoY) and operating losses (-$8.5M). Despite a healthy 66.8% gross margin, the company's capital structure is unsustainable with $25.1M debt against only $10.2M in total assets.

Strengths

  • + Gross margin of 66.8% demonstrates viable core product economics
  • + Current ratio of 1.22x provides near-term operational liquidity
  • + Maintains $2.6M cash reserves despite ongoing losses

Risks

  • ! Negative stockholders equity (-$23.1M) represents technical insolvency
  • ! Operating cash flow negative at -$2.6M indicating unsustainable burn rate
  • ! Revenue declining 12.8% YoY while operating losses expand
  • ! Quick ratio of 0.76x below 1.0 threshold signals liquidity stress
  • ! Long-term debt ($25.1M) exceeds total assets ($10.2M) creating debt crisis
  • ! Zero insider Form 4 filings in 90 days indicates management confidence collapse

Key Metrics to Watch

Financial Metrics

Revenue
30.4M
Net Income
-12.3M
EPS (Diluted)
$-1.27
Free Cash Flow
-2.7M
Total Assets
10.2M
Cash
2.6M

Profitability Ratios

Gross Margin 66.8%
Operating Margin -27.8%
Net Margin -40.6%
ROE N/A
ROA -121.4%
FCF Margin -8.9%

Balance Sheet & Liquidity

Current Ratio
1.22x
Quick Ratio
0.76x
Debt/Equity
N/A
Debt/Assets
327.5%
Interest Coverage
-4.32x
Long-term Debt
25.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-16T07:06:24.259168 | Data as of: 2025-12-31 | Powered by Claude AI